Events
| Regional Support Group Meeting Boise, ID |
October 4, 2008 |
| Alpha-1 Education Day Pittsburgh, PA |
October 18, 2008 |
To learn about events of interest to healthcare professionals, visit Conferences.
ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
Please review the Important Safety Information and the Full Prescribing Information
 |
To view PDF, you will need Adobe® Acrobat® Reader® software. |
